FDA to phase out 8 artificial dyes from food supply
It would be a sweeping change for U.S. food producers, who would likely replace the dyes with natural substitutes.
Health Care & Insurance
Articles
Roche picks Indiana for new plant, expanded operations as part of $50B investment in United States
Roche said Indiana would receive a new manufacturing facility for continuous glucose monitoring and expansion and upgrades at existing pharmaceutical, diagnostics and distribution operations.
Elevance posts first-quarter gains after top rival struggles
Weaker results posted this month by top rival UnitedHealth had raised concerns for others in the sector.
Kentucky auditor announces probe of state’s medical cannabis program
Auditor Allison Ball says her office received complaints about the lottery system used to award highly-sought-after licenses to businesses that will grow, process and sell the products.
Indiana senators send Medicaid work requirements to governor’s desk
Hoosiers getting insurance under the Healthy Indiana Plan would need to log at least 20 work or volunteer hours a week with the state, a move that supporters hope will curb the program’s enrollment numbers.
Indiana Court of Appeals weighs statute of limitations in fertility doctor deception case
The medical malpractice case centers on Dr. Donald Cline, the former Indianapolis fertility specialist who is believed to have deceptively fathered more than 90 children.
Roche Diagnostics hopes new self-collection HPV test will expand screening for cervical cancer risk
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
Trump orders new efforts to lower drug prices
Trump’s order contains proposals to further lower the cost of insulin, importing more low-cost drugs and streamlining the federal approval process for some drugs.
Bill targeting high hospital prices passed by Indiana Senate
The legislation threatens to strip large hospital systems of their state nonprofit status if they charge prices exceeding certain averages.
Community, Lifepoint to build behavioral health hospital in Westfield
The hospital is expected to treat conditions including major depression, anxiety disorders, suicidal thoughts, bipolar disorder, borderline personality disorder and schizophrenia.
Indiana Senate nears vote on bill scrutinizing nonprofit hospital prices
The Senate must still vote to pass the bill out of its chamber by Tuesday. The House will then decide whether it agrees with the Senate’s changes.
What is 340B and how does it impact hospitals’ bottom line?
The somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year.
Pfizer ends development of potential pill obesity treatment
Pfizer had been hoping the once-daily pill treatment would give it an edge over leading weight-loss treatments like Zepbound from Eli Lilly and Co. and Novo Nordisk’s Wegovy, which are injectable.
Bill targeting nonprofit hospital prices advances, faces more overhaul
An Indiana Senate committee voted to amend a bill targeting the cost of health care at nonprofit hospitals, with the new version freezing prices but not imposing penalties for two years.
Indiana joins growing list of states with 3 or more cases of measles
The United States has experienced more than double the number of measles cases it saw in all of 2024.
Elevance Health faces shareholder proposal on DEI practices
In its response to the proposal, Elevance touted that its “workforce embodies a multitude of dimensions.”
Indiana House GOP overwhelmingly votes to impose Medicaid work requirements
Under Senate Bill 2, those enrolled in the Healthy Indiana Plan will need to either work or volunteer for 20 hours each week, with several exceptions for caregivers, disabled beneficiaries and more.
OrthoIndy merging with Indiana Hand to Shoulder Center
The move is the latest expansion for OrthoIndy, which recently announced mergers with practices in Evansville and Fort Wayne.
Lilly sues Indianapolis clinic for selling split doses of popular weight-loss drugs
The drugmaker accuses Premier Weight Loss of risking patients’ health by selling altered, unsterile versions of its blockbuster drugs Mounjaro and Zepbound.
Trump administration nixes plan to cover anti-obesity drugs through Medicare
President Trump’s predecessor, Joe Biden, proposed a rule in late November after Trump won re-election that would have extended coverage of drugs like Zepbound and Wegovy.